American Century Companies
CATX icon

American Century Companies’s Perspective Therapeutics CATX Stock Holding History

American Century Companies’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Buy
35,722
+23,155
+184% +$97.8K ﹤0.01% 2745
2025
Q4 		$34.6K Buy
+12,567
New +$35.9K ﹤0.01% 2802

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies's CATX Position: Q1 2026 in Review

American Century Companies increased its Perspective Therapeutics (CATX) stake by 184% in Q1 2026, buying an estimated $97.8K and bringing the position to 35,722 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

American Century Companies first reported a position in CATX in Q4 2025 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • American Century Companies held 35,722 shares of Perspective Therapeutics worth $149K as of Q1 2026.
  • American Century Companies bought 23,155 Perspective Therapeutics shares in Q1 2026, an estimated $97.8K.
  • Perspective Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2745 holding.
  • American Century Companies first reported a position in Perspective Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.